TomoTherapy Incorporated that Edogawa Hospital has installed its second TomoTherapy treatment system, as part of an expansion of its cancer center in Tokyo. With the debut of this unit at Tokyo Edogawa Cancer Center (TECC), TomoTherapy reports that its installed base in Japan has grown to 16 treatment systems at 14 hospitals.
Takahiro Kato, M.D., Ph.D., vice-director at Edogawa Hospital said, TomoTherapy offers the platform of the future for radiation therapy. We first introduced TomoTherapySM treatments more than two years ago, and since that time we have been using it to capacity, specializing in highly precise treatment of prostate cancer. By adding a second unit we will be able to meet growing patient demand and bring this innovative radiation therapy solution to more cancer patients.
The TomoTherapy system is a versatile CT scanner-based device that integrates 3-D image guidance with helical delivery to provide continuous radiation therapy from all angles around the patient. The combination of these technologies results in highly conformal radiation therapy that provides clinicians improved dose control and patients with the potential for reduced treatment-related side effects. In addition, the TomoTherapy system offers easy-to-use software for treatment planning, quality assurance, patient set-up and treatment delivery, to streamline processes and speed treatment time.
Paul Baumgart, TomoTherapy’s general manager of Asia-Pacific Operations said, The addition of a second system at Edogawa Hospital and our growth in the Japanese market is a testament to the benefits that TomoTherapy provides to clinicians and patients alike. Working with our new distribution partner, Hitachi Medical Corporation, we have been able to reestablish Japan as a growth area for TomoTherapy, making it now our second largest market worldwide.
